Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Some birth control pills have a higher risk of blood clots than others.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgens significantly affect female hair loss, and hormonal treatments may help.